Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced BRAF Mutant Cancers × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 5 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Solid Tumors Harboring a BRAF V600 Mutation 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Disease Progression 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Advanced BRAF Mutant Cancers 1

Interventions

encorafenib 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03843775 2024-10-21

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed

17 enrolled 9 charts

Advanced BRAF Mutant Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡